"paper"

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19

Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

Humoral Immune Response to SARS-CoV-2 in Iceland

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'

Written by Kate Boor Ellis On 21 September 2020, Alzheimer Europe marked World Alzheimer’s Day with a social media campaign, calling attention to the damage COVID-19 is doing to the field of dementia research, together with a call for urgent… Continue Reading

October's Executive Page: Prof. Riccardo Soffietti

October's contribution to the Country of the Month: Serbia

In this paper, recently published in Stroke, the authors aimed to compare anterior circulation large vessel occlusion stroke severity between patients with and without COVID-19.

In this paper, recently published in Neurocritical Care, the authors conducted a retrospective cohort study of patients with haemorrhagic stroke (both non-traumatic intracerebral haemorrhage and spontaneous non-aneurysmal subarachnoid haemorrhage) who were hospitalised between March 1, 2020, and May 15, 2020, within a major healthcare system in New York, during the coronavirus pandemic.

In this paper, recently published in Arteriosclerosis, Thrombosis, and Vascular Biology, the authors aimed to determine the prevalence of D-dimer elevation in COVID-19 hospitalisation, trajectory of D-dimer levels during hospitalisation, and association with clinical outcomes.

In this paper, recently published in the European Journal of Neurology, the authors reported four cases of COVID‐19‐related encephalopathy. The diagnosis was made in patients with confirmed COVID‐19 who presented with new‐onset cognitive disturbances, central focal neurological signs or seizures.

In this paper, recently published in the Journal of Neurology, Neurosurgery and Psychiatry, the authors report initial findings of an ongoing community based COVID-19 study in a large UK-wide population of people with multiple sclerosis (pwMS) which coincided with the peak of the COVID-19 outbreak in the UK

Acute cerebrovascular disease, particularly ischaemic stroke, has emerged as a serious complication of COVID-19.